All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Creative Biolabs is committed to providing overall solutions for biomarker development for immunologic monitoring, focusing on innovative research. Protein microarray is a powerful technology for biomarker discovery in high throughput format. Our team has extensive experience in applying protein microarrays for biomarker discovery, providing accurate and effective solutions for researchers all over the world.
Biomarkers indicate the state of a biological process, differentiating if it is normal or pathological. They are all those molecules that are found in body fluids in low abundance and that are associated with specific health or disease processes. The methodology to establish that a biomarker is good for clinical application is divided into three steps, including discovery, verification and validation. Proteomics has identified several proteins that can act as biomarkers. Protein microarray is one of the advanced techniques in proteomics used for biomarker identification, supporting early diagnosis and Immunologic monitoring. Analysis of microarray data has become a useful tool for the study of different illnesses including all types of cancer.
Fig.1 The general outline of any protein microarray workflow. (Neagu, 2019)
Biomarker research and its translation into the clinics have been accelerated by protein microarrays due to the extraordinary capacity for identifying valuable biomarkers in a short period without the requirement of any prior in-depth knowledge into the mechanism of disease progression.
Based on our advanced Immunologic Monitoring Platform, Creative Biolabs offers accurate and effective solutions for researchers who are committed to biomarker development for immunologic monitoring. Protein microarray is an efficient strategy for biomarker discovery. At Creative Biolabs, mostly human proximal body fluids, such as plasma, serum, and synovial liquid, are available for analyzing targeted/non-targeted biomarkers by protein microarrays, including antibody microarrays and functional protein microarrays. Our multidisciplinary platform teams work together closely to address the scientific and technical challenges in biomarker development for immunologic monitoring.
Antibodies are printed onto an array surface. Multiplexed affinity reagents are used to detect proteins in complex biological samples. Based on the antibody-antigen interaction, particular or rare analytes can be detected in highly heterogeneous mixtures. Therefore, antibody microarrays are usually used to identify biomarkers that predict a healthy or pathologic condition.
Recombinant proteins are printed onto an array surface. Based on the identification of protein interactions with different molecules, this technology is useful in unbiased high throughput screening of antibody biomarkers for a variety of human diseases.
Scientists at Creative Biolabs are proficient at applying protein microarray technology for biomarker discovery. With proven experience in biomarker discovery, Creative Biolabs is an ideal company to entrust with your business. For more detailed information, please feel free to contact us or directly send us an inquiry.
Reference
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION